1) Anterior mediastinal mass -Thymomas → local compression, e.g. hest pain, shortness of breath, cough, phrenic nerve palsy -Thymic carcinoma → more local invasive, distant metastasis is rare.
2) Parneoplasm symptoms -Myasthenia gravis -Pure red cell aplasia -Hypogammaglobulenemia/immmunodeficiency
Biology:
Undefined
Pathology:
A. IHC: Epithelial cells + lymphocytes + Cytokeratin B.. WHO Types: 1) Type A thymoma: medullary thymoma (9%).
2) Type AB thymoma: mixed thymoma (24%).
3) Type B -B1: 13%, predominantly cortical thymoma, lymphocyte rich -B2: 24% -B3: well-differentiated thymic carcinoma, 15%. 4) Thymic carcinoma:
In general, encapsulated tumors (type A and AB) are associated with stage I or II disease, whereas types B1, B2, and B3, and thymic carcinoma are more frequently associated with invasion into adjacent organs or with disseminated disease (stages III and IV).
C. Staging

UpToDate:
Sutent and mTOR inhitor may have activities in thymic carcinoma.
Prognosis:
1) Thymomas are slow-growing, and the presence of invasion is an important adverse prognostic marker. Thymic carcinomas are more aggressive and have poorer prognosis. → If complete resection is NOT possible, debulking with subtotal resection, followed by RT (improve survival) → Although thymomas is chemo-sensitive, chemo dubulking is still invastigational. 
